
<!DOCTYPE html>
<html lang="en">
	<head>
		<meta charset="UTF-8">
		<meta name="viewport" content="width=device-width, initial-scale=1.0">
		<title>iDEC NKLMI-NK_drug 2023</title>
		<link rel="stylesheet" type="text/css" href="../css/main_cssstyle.css">
				        <link rel="stylesheet" type="text/css" href="../css/loader.css">
		<style>
			header {
				background: url("../images/back.jpg");
				min-height: 70%;
				background-repeat: no-repeat;
				background-size: cover;
				background-position: center center;
			}

			.page-title {
				padding-top: 10em;
				padding-bottom: 1.5em;
			}
			.literature{
				font-size: 1.2em;
			}
			#a1,#a2,#a3,#a4{
				text-decoration: none;
			}
		</style>
	</head>
	<body>
	    
	         <!-- 页面加载动画 -->
    <div id="loader">
        <div aria-busy="true" aria-label="Loading" role="progressbar" class="loader-container">
            <img  src="../images/load.gif">
        </div>
    </div>
		<a class="skip-main" href="#slide1-chapter1">Skip to main content</a>
		<header>
		<nav id="normal-nav">
				<!---- 正常情况下顶部导航栏Navigation bar (normal) -->
				<div class="logo">
					<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/">
						<img id="nav-logo" src="../images/logo.png"
							alt="This is our logo, but if you click it, you will return home">
					</a>
				</div>
				<div class="chapters">
					<div class="dropdown-menu cool-link">
						<a class="chapter-nav " href="https://idec-teams.github.io/2023_NKLMI-NK_drug/">
							<div class="chapter-content">
								<div class="chapter-title active ">
									Home
								</div>
							</div>
						</a>
					</div>
					<div class="dropdown-menu cool-link">
						<a class="chapter-nav " href="#">
							<div class="chapter-content">
								<div class="chapter-title active ">
									Team
								</div>
								<div class="chapter-icon">
									<i class="fas fa-sort-down"></i>
								</div>
							</div>
						</a>
						<div class="dropdown-content">
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/team/members.html" class="dropdown-page cool-link2">
								Members
							</a>
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/team/attributions.html" class="dropdown-page cool-link2">
								Attributions
							</a>
						</div>
					</div>
					<div class="dropdown-menu cool-link">
						<a class="chapter-nav " href="#">
							<div class="chapter-content">
								<div class="chapter-title active ">
									Project
								</div>
								<div class="chapter-icon">
									<i class="fas fa-sort-down"></i>
								</div>
							</div>
						</a>
						<div class="dropdown-content">
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/project/background.html" class="dropdown-page cool-link2">
								Background
							</a>
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/project/design.html" class="dropdown-page cool-link2">
								Design
							</a>
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/project/results.html" class="dropdown-page cool-link2">
								Results
							</a>
							<a href="../images/report.pdf" class="dropdown-page cool-link2" target="_blank">
								Report
							</a>
							<a href="../images/supplementary.pdf" class="dropdown-page cool-link2" target="_blank">
								Supplementary information
							</a>
						</div>
					</div>
					<div class="dropdown-menu cool-link">
						<a class="chapter-nav " href="#">
							<div class="chapter-content">
								<div class="chapter-title active ">
									Documentation
								</div>
								<div class="chapter-icon">
									<i class="fas fa-sort-down"></i>
								</div>
							</div>
						</a>
						<div class="dropdown-content">
							
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/documentation/notebook.html" class="dropdown-page cool-link2">
								Notebook
							</a>
						
							<a href="https://idec-teams.github.io/2023_NKLMI-NK_drug/documentation/protocol.html" class="dropdown-page cool-link2">
								Protocol
							</a>
						</div>
					</div>
				</div>
			</nav>
			<!------------ 页面标题PAGE TITLE -------------------->
			<div class="page-title">
				<div class="page-title-content">
					<!--<h1>BACKGROUND</h1>-->
					<!---Page title -->
				</div>
			</div>
		</header>
		<div class="grid-normal">
			<!--------------Introduction/Summary--------------------->
			<div class="introduction grid-normal">
			</div>
		</div>
		<div style="display:none" id="marker" class="triangle-down"> </div>
		<!------------------ BUTTONS ---------------------------->
		<div class="buttons">
		</div>
		<div class="sections-container">
			<aside class="sticky">
				<div id="sub-nav" class="sub-navigation-content">
					<div class="sub-navigation-chapter cool-link2">
						<a class="main-nav-link" linkedidchapter="slide1-chapter1">Part One</a>
				
					</div>
					<div class="sub-navigation-chapter cool-link2">
						<a class="main-nav-link" linkedidchapter="slide1-chapter2">Part Two</a>
				
					</div>
					<div class="sub-navigation-chapter cool-link2">
						<a class="main-nav-link" linkedidchapter="slide1-chapter3">Part Three</a>
			
					</div>
							<div class="sub-navigation-chapter cool-link2">
						<a class="main-nav-link" linkedidchapter="slide1-chapter4">Reference</a>
			
					</div>
					  
					<div id="to-top-arrow">
						<a title="Back to top" href="#"><i class="fas fa-chevron-circle-up"></i></a>
					
					</div>
				</div>
			</aside>
			<div class="carousel">
				<div class="slider">
					<!------------------------------ section 1------------------------------------>
					<section class="slide-sections">
						<div class="main-body">
							<div class="main-body-content">
								<div id="slide1-chapter1">
									<div style="margin-top: 40px">
										<h2>Pressure directed evolution</h2>
									
										<p>
						Heterogeneity lies in different individuals of the same species. When in a certain state of stress, individuals who are more adapted to the environment will have a greater probability of survival and reproduction, which is reflected in the evolution of population to a certain phenotype in terms of population size. In a similar way, based on the concept of molecular directed evolution, after artificially inducing massive genetic mutation in Nature Killer (NK) cells, we applied the referred orthotopic PDAC model to offer them a tumor-bearing environment pressure. The NK cells which have the strongest viability and biological function were then selected, completing an artificial evolution targeting anti-tumor efficacy.
										</p>
							<img src="../images/p1.jpg" alt="" style="width:80%" />
								<img src="../images/p2.jpg" alt="" style="width:80%" />
									</div>
								</div>
								<div id="slide1-chapter2">
									<h2>CRISPR Screen </h2>
									<p>
									The clustered regularly interspaced short palindromic repeats (CRISPR) system was first discovered in bacteria as an effective means to resist virus invasion. Cleverly modified, now it can be used for gene edit, namely, under the guidance of guide RNA (gRNA), targeting regions in the genome and cutting DNA, to achieve gene knockout. By regulating the biological activity of cas9, CRISPR activation and interference systems can up-regulate or silence the expression of specific genes in target cells. Bases on this technology, we employed a Gain-of-Function (GOF) dgRNA library to conduct genome-scale activation screening.
									</p>
											<img src="../images/p3.jpg" alt="" style="width:80%" />
								</div>
								<div id="slide1-chapter3" style="margin-bottom: 5%;">
									<h2>Our Model</h2>
							
						
							<p>	Pancreatic ductal adenocarcinoma (PDAC) is a common malignant tumor pathological type of pancreatic cancer, with a five-year survival rate of 12%. Due to the immunosuppressive tumor microenvironment (TME), the strategy of "neoadjuvant therapy" is constantly refined. To reach the surgical criteria, we can utilize targeted drugs or immunotherapy to kill some tumor cells in advance. Immune cells, such as NK cells, T cells and macrophages are all of vital importance.	</p>	<p>
In order to meet research needs, several PDAC animal models have been described, including the heterotopic and orthotopic ones. For the simplification and success rate, heterotopic flank tumors are frequently used, but the anatomical position effect should be given enough concern. The traditional orthotopic injection method not only requires high quality operation, but may also results in acute pancreatitis and even perioperative death. In our project, we applied a novel orthotopic implantation of PDAC tissue slices that could simulate the real TME relatively stable and reduce the failure rate of surgery.	</p>

				<img src="../images/p4.jpg" alt="" style="width:100%" />
								</div>
										<div id="slide1-chapter4">
									<h2>Reference</h2>
							
						
							<p>1 	SIEGEL R L, MILLER K D, WAGLE N S, et al. Cancer statistics, 2023 [J]. CA 	Cancer J Clin, 2023, 73(1): 17-48.</p><p>
2	SPRINGFELD C, FERRONE C R, KATZ M H G, et al. Neoadjuvant therapy for 	pancreatic cancer [J]. Nat Rev Clin Oncol, 2023, 20(5): 318-37.</p><p>
3	HERBERMAN R B, NUNN M E, LAVRIN D H. Natural cytotoxic reactivity of 	mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of 	reactivity and specificity [J]. Int J Cancer, 1975, 16(2): 216-29.</p><p>
4	KIESSLING R, KLEIN E, WIGZELL H. "Natural" killer cells in the mouse. I. 	Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity 	and distribution according to genotype [J]. Eur J Immunol, 1975, 5(2): 112-7.</p><p>
5	SPITS H, ARTIS D, COLONNA M, et al. Innate lymphoid cells--a proposal for 	uniform nomenclature [J]. Nat Rev Immunol, 2013, 13(2): 145-9.</p><p>
6	LIU D F, BRYCESON Y T, MECKEL T, et al. Integrin-Dependent Organization 	and Bidirectional Vesicular Traffic at Cytotoxic Immune Synapses [J]. Immunity, 	2009, 31(1): 99-109.</p><p>
7	COOLEY S, HE F, BACHANOVA V, et al. First-in-human trial of rhIL-15 and 	haploidentical natural killer cell therapy for advanced acute myeloid leukemia [J]. 	Blood Adv, 2019, 3(13): 1970-80.</p><p>
8	WANG J, JENSEN M, LIN Y, et al. Optimizing adoptive polyclonal T cell 	immunotherapy of lymphomas, using a chimeric T cell receptor possessing CD28 	and CD137 costimulatory domains [J]. Hum Gene Ther, 2007, 18(8): 712-25.</p><p>
9	QUINTARELLI C, SIVORI S, CARUSO S, et al. Efficacy of third-party 	chimeric antigen receptor modified peripheral blood natural killer cells for 	adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia [J]. 	Leukemia, 2020, 34(4): 1102-15.<p>
10	WANG X, JASINSKI D L, MEDINA J L, et al. Inducible MyD88/CD40 		synergizes with IL-15 to enhance antitumor efficacy of CAR-NK cells [J]. Blood 	Adv, 2020, 4(9): 1950-64.</p><p>
11	LI R, JOHNSON R, YU G, et al. Preservation of cell-based immunotherapies 	for 	clinical trials [J]. Cytotherapy, 2019, 21(9): 943-57.</p><p>
12	PARIHAR R, RIVAS C, HUYNH M, et al. NK Cells Expressing a Chimeric 		Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell 	Activity against Solid Tumors [J]. Cancer Immunol Res, 2019, 7(3): 363-75.</p><p>
13	ISHINO Y, SHINAGAWA H, MAKINO K, et al. Nucleotide sequence of the iap 	gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, 	and identification of the gene product [J]. J Bacteriol, 1987, 169(12): 5429-33.</p><p>
14	KNOTT G J, DOUDNA J A. CRISPR-Cas guides the future of genetic 	engineering [J]. Science, 2018, 361(6405): 866-9.</p><p>
15	QI L S, LARSON M H, GILBERT L A, et al. Repurposing CRISPR as an 			RNA-Guided Platform for Sequence-Specific Control of Gene Expression [J]. 	Cell, 2013, 152(5): 1173-83.</p><p>
16	KOMOR A C, KIM Y B, PACKER M S, et al. Programmable editing of a target 	base in genomic DNA without double-stranded DNA cleavage [J]. Nature, 2016, 	533(7603): 420-4.

</p>


								</div>
							</div>
						</div>
					</section>
				</div>
			</div>
		</div>
		<a href="#" id="mobile-to-top-arrow" class="to-top">

			<img style="max-height: 90px" src="../images/top.png">
		</a>
		<!---------- 页脚FOOTER ------------>
    <footer>
        <!-- 头部波浪效果 -->
        <div class="footer-header" style="background:white">
            <svg class="footer-waves" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"
                viewBox="0 24 150 28" preserveAspectRatio="none" shape-rendering="auto">
                <defs>
                    <path id="footer-gentle-wave"
                        d="M-160 44c30 0 58-18 88-18s 58 18 88 18 58-18 88-18 58 18 88 18 v44h-352z" />
                </defs>
                <g class="footer-parallax">
                    <use xlink:href="#footer-gentle-wave" x="48" y="0" fill="#8FC4E3" />
                    <use xlink:href="#footer-gentle-wave" x="48" y="3" fill="#FFBD80" />
                    <use xlink:href="#footer-gentle-wave" x="48" y="5" fill="#FFED60" />
                    <use xlink:href="#footer-gentle-wave" x="48" y="7" fill="#F6D1D9" />
                </g>
            </svg>
        </div>
    </footer>


		<script src="../js/jQuery.js" type=text/javascript></script>
		<script src="../js/detect.js" type="text/javascript"></script>
		<script src="../js/main_javascript.js" type=text/javascript></script>
		<script src="../js/MoveContent.js" type="text/javascript"></script>


		<script>
			document.addEventListener("DOMContentLoaded", function(event) {
				MoveContentOutside();
			});
		</script>
				 	<script src="../js/loader.js" type="text/javascript"></script>
	</body>
</html>
>>